Stock Price
1,739.00
Daily Change
-12.50 -0.71%
Monthly
28.10%
Yearly
-6.23%
Q3 Forecast
1,726.10

Genmab reported DKK423M in Pre-Tax Profit for its fiscal quarter ending in June of 2025.




Pre Tax Profit Change Date
Agios Pharmaceuticals USD -112020000 22.73M Jun/2025
Almirall EUR 35.8M 37.9M Mar/2025
Amarin USD -13630000 197K Mar/2025
Amgen USD 1.57B 405M Jun/2025
argenx SE USD 286.9M 84.54M Jun/2025
AstraZeneca USD 3.13B 275M Jun/2025
Bayer EUR -426000000 2.26B Jun/2025
BioMarin Pharmaceutical USD 297.87M 59.78M Jun/2025
Demant DKK 1.46B 497M Jun/2025
Exelixis USD 230.42M 24.72M Jun/2025
Fresenius Medical Care EUR 350.55M 99.9M Jun/2025
Galapagos EUR -156367000 175.4M Mar/2025
Genmab DKK 423M 179M Jun/2025
GlaxoSmithKline GBP 1.89B 221M Jun/2025
GN Store Nord DKK 232M 118M Jun/2025
GRIFOLS EUR 190.51M 20.03M Jun/2025
Hikma Pharmaceutical USD 144M 144M Jun/2024
Insmed USD -320443000 64.77M Jun/2025
Lonza CHF 624M 197M Dec/2024
Merck EUR 829M 127M Jun/2025
Novartis USD 4.53B 124M Jun/2025
Regeneron Pharmaceuticals USD 1.52B 613.7M Jun/2025
Roche Holding CHF 1.78B 2.33B Dec/2024
Sanofi EUR 1.42B 734M Jun/2025
UCB EUR 1.22B 781M Dec/2024